Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-15

Clinical Trial Update: Oral Isotretinoin for Photoaging: Results of a Randomized Controlled Phase II Trial [Phase 2]

View source ↗

Summary

Phase II randomized trial assessing oral isotretinoin for photoaging, reporting results after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

Sponsor: Federal University of São Paulo | Conditions: Photoaging, Epidermal p53 Expression | Phase 2 | Status: COMPLETED